
Primary Care and EDS - Mayo Clinic Connect
2022年1月28日 · A frequently asked question by patients with EDS/HSD is “who should I follow with for my annual visits?” Every patient should follow with a primary care provider (aka “PCP”) …
Diagnosis and Management of Hypermobility Spectrum Disorders in Primary ...
Hypermobility spectrum disorders (HSDs) encompass an array of connective tissue disorders characterized by joint instability and chronic pain. Fatigue and other systemic symptoms that …
Care Model - Hypermobility Consulting
Hypermobility Consulting will partner with your Primary Care Physician (PCP) or primary care clinician to implement your specific care plan. Your PCP will know your care plan and should …
EDS Clinic Patient Stories - Mayo Clinic Connect
2023年12月12日 · Patients can suffer debilitating setbacks from symptoms of EDS/HSD, so it’s important to take the opportunity to highlight patient success stories. We have started a series …
The need for primary care providers in the clinical management of ...
2024年8月7日 · Patients with joint-hypermobility and joint-hypermobility spectrum disorders (HSD), including hypermobile Ehlers-Danlos Syndromes (EDS) present numerous co-morbid …
EDS familiar PCP - Ehlers-Danlos Syndromes - Inspire
2025年3月17日 · Can anyone recommend an EDS aware PCP who accepts insurance in Philadelphia, Jenkintown, Willow Grove, Abington, Doylestown, PA? Ehlers-Danlos …
PCP - Ehlers-Danlos Syndromes - Inspire
2021年8月6日 · Looking for any PCP in the Massachusetts area that is familiar with EDS :)
Diagnosis and Management of Hypermobility Spectrum Disorders …
Diagnostic criteria for hEDS include measures of joint hypermobility, skin and other connective tissue findings, and lack of evidence of a different type of Ehlers-Danlos syndrome.
PCP Recommendations in Washington, DC Area - Inspire
2024年12月22日 · I was diagnosed with hEDS as a kid and have since moved to the Washington DC area. My PCP knows nothing about EDS and has not been able to help properly diagnose …
The metabolic activation of pentachlorophenol to chloranil as a …
The results showed that PCP exhibited moderate inhibition of human 3β-HSD1, with an IC 50 value of 29.83 μM and displayed mixed inhibition in terms of mode of action. Conversely, …